Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 May 25;17(1):369.
doi: 10.1186/s12913-017-2202-7.

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol

Laura A Young  1   2 , John B Buse  3   4 , Mark A Weaver  5 , Maihan B Vu  6 , April Reese  7 , C Madeline Mitchell  4 , Tamara Blakeney  4 , Kimberlea Grimm  4 , Jennifer Rees  4 , Katrina E Donahue  4   8
Affiliations
Randomized Controlled Trial

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol

Laura A Young et al. BMC Health Serv Res. .

Abstract

Background: For the nearly 75% of patients living with type 2 diabetes (T2DM) that do not use insulin, decisions regarding self-monitoring of blood glucose (SMBG) can be especially problematic. While in theory SMBG holds great promise for sparking favorable behavior change, it is a resource intensive activity without firmly established patient benefits. This study describes our study protocol to assess the impact of three different SMBG testing approaches on patient-centered outcomes in patients with non-insulin treated T2DM within a community-based, clinic setting.

Methods/design: Using stakeholder engagement approach, we developed and implemented a pragmatic trial of patient with non-insulin treated T2DM patients from five primary care practices randomized to one of three SMBG regimens: 1) no testing; 2) once daily testing with standard feedback consisting of glucose values being immediately reported to the patient through the glucose meter; and 3) once daily testing with enhanced patient feedback consisting of glucose values being immediately reported to the patient PLUS automated, tailored feedback messaging delivered to the patient through the glucose meter following each testing. Main outcomes assessed at 52 weeks include quality of life and glycemic control.

Discussion: This pragmatic trial seeks to better understand the value of SMBG in non-insulin treated patients with T2DM. This paper outlines the protocol used to implement this study in fifteen community-based primary care practices and highlights the impact of stakeholder involvement from the earliest stages of project conception and implementation. Plans for stakeholder involvement for result dissemination are also discussed.

Trial registration: ClinicalTrials.gov NCT02033499 , January 9, 2014.

Keywords: Glycemic control; Pragmatic clinical trial; SMBG; Self-monitoring of blood glucose; Type 2 diabetes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study Arms
See this image and copyright information in PMC

References

    1. Malanda UL, Bot SD, Nijpels G. Self-monitoring of blood glucose in noninsulin-using type 2 diabetic patients: it is time to face the evidence. Diabetes Care. 2013;36:176–178. doi: 10.2337/dc12-0831. - DOI - PMC - PubMed
    1. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37 Suppl 1:S14-80. - PubMed
    1. Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin. 2009;25:2903–2913. doi: 10.1185/03007990903364665. - DOI - PubMed
    1. Clar C, Barnard K, Cummins E, Royle P, Waugh N, Aberdeen Health Technology Assessment G Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess (Winchester, England) 2010;14:1–140. - PubMed
    1. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. Br Med J. 2012;344:e486–6. - PubMed

Publication types

Associated data